Related topics: Industry Drivers
Pfizer, the “world’s largest research-based drug company,” will cut 800 R&D jobs at facilities in Groton, Connecticut, St. Louis, Missouri, La Jolla, California, US and Sandwich, UK by the end of the year.
The US giant has been making extensive cutbacks for the last few years, shedding some 14,000 jobs since 2007 in a bid to trim down and prepare for impending generic competition for some of its leading brands.
The latest plans are part of September’s announcement that saw Pfizer shift its R&D away from its traditional strengths like heart drugs and obesity treatment to focus on biologics and other high-tech treatments for cancer and Alzheimer’s.
Copyright - Unless otherwise stated all contents of this web site are © 2000/2009 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
© 2000/2009 - Decision News Media SAS - All right reserved.
